02697nam 2200685Ia 450 991096811850332120251116231533.00-429-52568-00-429-13772-91-281-73192-797866117319221-4200-5294-2(CKB)1000000000537580(EBL)354105(OCoLC)476175660(SSID)ssj0000220627(PQKBManifestationID)11218565(PQKBTitleCode)TC0000220627(PQKBWorkID)10144025(PQKB)10594449(MiAaPQ)EBC3059666(OCoLC)1039523809(OCoLC-P)1039523809(FlBoTFG)9780429137723(OCoLC)190867355(FINmELB)ELB140648(EXLCZ)99100000000053758020080109d2008 uy 0engurcnu||||||||txtccrPharmacogenetics of breast cancer towards the individualization of therapy /edited by Brian Leyland-Jones1st ed.New York Informa Healthcare USAc20081 online resource (352 p.)Translational medicine series ;7Description based upon print version of record.1-4200-8637-5 1-4200-5293-4 Includes bibliographical references and index.Front Cover; Preface; Acknowledgments; Contents; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Chapter 19; Chapter 20; Index; Back Cover; Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become rout.Translational medicine series ;7.BreastCancerGenetic aspectsBreastCancerChemotherapyPharmacogeneticsBreastCancerGenetic aspects.BreastCancerChemotherapy.Pharmacogenetics.616.99449061Leyland-Jones Brian1872821MiAaPQMiAaPQMiAaPQBOOK9910968118503321Pharmacogenetics of breast cancer4482638UNINA